首页> 外文期刊>Malaria research and treatment >Review of Temephos Discriminating Concentration for Monitoring the Susceptibility ofAnopheles labranchiae(Falleroni, 1926), Malaria Vector in Morocco
【24h】

Review of Temephos Discriminating Concentration for Monitoring the Susceptibility ofAnopheles labranchiae(Falleroni, 1926), Malaria Vector in Morocco

机译:监测用于监测疟疾媒介的拉曼按蚊易感性的Temephos鉴别浓度(Falleroni,1926)

获取原文
           

摘要

In Morocco, the resistance monitoring ofAnopheles labranchiaelarvae to temephos is done using discriminating concentration of 0.125 mg, which is half of the WHO recommended dose forAnopheles. However, this dosage seemed to be too high to allow an early detection of the resistance and its revision was found necessary. The present study was carried out during May-June 2008 and 2009 in nine provinces from the north-west of the country. The aim was to determine the lethal concentrations LC100 of temephos for the most susceptible populations and to define the discriminating dosage as the double of this value. The bioassays were conducted according to WHO standard operating protocol to establish the dose-mortality relationship and deduct the LC50 and LC95. The results of this study indicated that the LC100 obtained on the most susceptible populations was close to 0.05 mg/L. Therefore, the temephos discriminating dosage for susceptibility monitoring ofAn. labranchiaelarvae in Morocco was set to be 0.1 mg/L.
机译:在摩洛哥,使用区分浓度为0.125μmg的浓度来监测拉布氏按蚊幼虫对坦弗洛斯的耐药性,这是WHO对按蚊推荐剂量的一半。但是,该剂量似乎过高,无法早期检测出耐药性,因此发现有必要对其进行修正。本研究于2008年5月至2009年6月以及该国西北部的9个省进行。目的是确定最易感人群的替米非斯的致死浓度LC100,并将区分剂量定义为该值的两倍。根据WHO标准操作规程进行生物测定,以建立剂量-死亡率关系并扣除LC50和LC95。这项研究的结果表明,在最易感人群上获得的LC100接近0.05μmg/ L。因此,对安非他明药的易感性监测应采用辨别剂量。摩洛哥的labranchiaelarvae设定为0.1μmg/ L。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号